Tumor Ablation Market By Technology, Treatment And Application- Global Industry Analysis And Forecast To 2023
- Category: Healthcare
- Published Date: Jul 2022
- Publisher: Crystal Market Research
- Pages: 190
Industry Outlook and Trend Analysis
The Tumor Ablation Market was worth USD 0.28 billion in 2017 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period. Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.
Technology Outlook and Trend Analysis
Radiofrequency tumor ablation technology held considerable share in 2017. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.
Treatment Outlook and Trend Analysis
Surgical ablation fragment held significant share of 42.1% of every 2017. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.
Application Outlook and Trend Analysis
Liver cancer represented biggest shares in 2017. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).
Regional Outlook and Trend Analysis
North America ruled the general tumor ablation market with more than 32.0% share in 2017. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.
Competitive Insights
The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.
The Tumor Ablation Market is segmented as follows-
By Technology:
Microwave ablation
Cryoablation
Radiofrequency ablation
Other ablation technologies
By Treatment:
Surgical tumor ablation
Laparoscopic tumor ablation
Percutaneous tumor ablation
By Application:
Liver cancer
Breast cancer
Lung cancer
Prostate cancer
Other cancers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
South Africa
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2017 and forecast from 2017 to 2023?
What will be the industry market growth from 2017 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
The Tumor Ablation Market was worth USD 0.28 billion in 2017 and is expected to reach approximately USD 0.86 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.15% during the forecast period. Expanding pervasiveness of cancer is the main consideration contributing for the development of the market. On the basis of the insights published by World Health Organization (WHO), around 13% of the general population suffer from cancer around the world. Furthermore, there is 70.0% ascent in cancer cases expected throughout the following couple of decades. Hence, in excess of 100 cancer composes need tumour ablation in this manner boosting market development over the conjecture time frame. Technological progressions in the field of thermal ablation technologies are expected to fuel market development. The fast ascent in maturing populace is anticipated to increase.
Technology Outlook and Trend Analysis
Radiofrequency tumor ablation technology held considerable share in 2017. Radiofrequency ablation uses of imaging devices and needle electrode probe to pierce through skin. High recurrence currents are gone through electrode for creating heat in order to decimate tumor cells. These electric currents create sound waves; these waves at that point produce warm responding target cell particle. Increasing application of this innovation in solid tumor removal everywhere throughout the body and its specificity contributed its development.
Treatment Outlook and Trend Analysis
Surgical ablation fragment held significant share of 42.1% of every 2017. Expanded pervasiveness of cancers such as liver disease and breast cancer, which require open surgical methods, added to development of surgical procedures. Nonetheless, percutaneous procedures are anticipated to reflect lucrative development over the estimate time frame. Rising interest for minimally invasive surgeries is high-affect rendering factor adding to their development. These methods offer quicker recovery, diminished scarring, and expanded security.
Application Outlook and Trend Analysis
Liver cancer represented biggest shares in 2017. Liver cancer is most common in males as opposed to females, and rising rate of bile duct cancer and also primary liver cancer brought about their dominion. Lung cancer has been expected to develop with the most astounding CAGR amid the conjecture time frame. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC).
Regional Outlook and Trend Analysis
North America ruled the general tumor ablation market with more than 32.0% share in 2017. Main factors adding to development of this district incorporate support of the government for quality healthcare, availability of reimbursement, high purchasing power parity, and expanding predominance of growths in the U.S. also, Canada. In expansion, accuracy prescription activity is detailing the custom fitted procedures on exceptional qualities of diseases.
Competitive Insights
The leading players in the market are AngioDynamics Inc, Galil Medical Inc, SonaCare Medical, Boston Scientific, EDAP TMS S.A, HealthTronics Inc, Medtronic, NeuWave Medical and MISONIX Inc. These industry players have implemented different methodologies to support their position in the market. For example, collaborations, new product launches, mergers and acquisitions, technological advancements are the most well-known activities in this industry.
The Tumor Ablation Market is segmented as follows-
By Technology:
Microwave ablation
Cryoablation
Radiofrequency ablation
Other ablation technologies
By Treatment:
Surgical tumor ablation
Laparoscopic tumor ablation
Percutaneous tumor ablation
By Application:
Liver cancer
Breast cancer
Lung cancer
Prostate cancer
Other cancers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
South Africa
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2017 and forecast from 2017 to 2023?
What will be the industry market growth from 2017 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Tumor Ablation Market, By Technology
5.1. Introduction
5.2. Global Tumor Ablation Sales, Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Tumor Ablation Sales and Sales Share by Technology (2017-2027)
5.2.2. Global Tumor Ablation Revenue and Revenue Share by Technology (2017-2027)
5.3. Radiofrequency
5.3.1. Global Radiofrequency Sales and Growth Rate (2017-2027)
5.4. Microwave ablation
5.4.1. Global Microwave ablation Sales and Growth Rate (2017-2027)
5.5. Cryoablation
5.5.1. Global Cryoablation Sales and Growth Rate (2017-2027)
5.6. Other ablation technologies
5.6.1. Global Other ablation technologies Sales and Growth Rate (2017-2027)
6. Tumor Ablation Market, By Treatment
6.1. Introduction
6.2. Global Tumor Ablation Sales, Revenue and Market Share by Treatment (2017-2027)
6.2.1. Global Tumor Ablation Sales and Sales Share by Treatment (2017-2027)
6.2.2. Global Tumor Ablation Revenue and Revenue Share by Treatment (2017-2027)
6.3. Surgical tumor ablation
6.3.1. Global Surgical tumor ablation Sales and Growth Rate (2017-2027)
6.4. Laparoscopic tumor ablation
6.4.1. Global Laparoscopic tumor ablation Sales and Growth Rate (2017-2027)
6.5. Percutaneous tumor ablation
6.5.1. Global Percutaneous tumor ablation Sales and Growth Rate (2017-2027)
7. Tumor Ablation Market, By Application
7.1. Introduction
7.2. Global Tumor Ablation Sales, Revenue and Market Share by Application (2017-2027)
7.2.1. Global Tumor Ablation Sales and Sales Share by Application (2017-2027)
7.2.2. Global Tumor Ablation Revenue and Revenue Share by Application (2017-2027)
7.3. Liver cancer
7.3.1. Global Liver cancer Sales and Growth Rate (2017-2027)
7.4. Breast cancer
7.4.1. Global Breast cancer Sales and Growth Rate (2017-2027)
7.5. Lung cancer
7.5.1. Global Lung cancer Sales and Growth Rate (2017-2027)
7.6. Prostate cancer
7.6.1. Global Prostrate cancer Sales and Growth Rate (2017-2027)
7.7. Other Cancers
7.7.1. Global Other cancers Sales and Growth Rate (2017-2027)
8. Tumor Ablation Market, By Region
8.1. Introduction
8.2. Global Tumor Ablation Sales, Revenue and Market Share by Regions
8.2.1. Global Tumor Ablation Sales by Regions (2017-2027)
8.2.2. Global Tumor Ablation Revenue by Regions (2017-2027)
8.3. North America Tumor Ablation by Countries
8.3.1. North America Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.2. North America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.3.3. North America Tumor Ablation Sales by Countries (2017-2027)
8.3.4. North America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.5.2. United States Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Tumor Ablation Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Tumor Ablation by Countries
8.4.1. Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.2. Europe Tumor Ablation Revenue and Growth Rate (2017-2027)
8.4.3. Europe Tumor Ablation Sales by Countries (2017-2027)
8.4.4. Europe Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.6.2. UK Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.7.2. France Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Tumor Ablation Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Tumor Ablation Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.5.2. China Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.8.2. India Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.2. South America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.6.3. South America Tumor Ablation Sales by Countries (2017-2027)
8.6.4. South America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Tumor Ablation Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Tumor Ablation Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Medtronic Plc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Angiodynamics
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Mermaid Medical
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. HealthTronics
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Galil Medical Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. EDAP TMS S.A.
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Boston Scientific Corporation
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Sonacare Medical
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Misonix, Inc.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
9.10. Neuwave Medical, Inc.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Sales, Revenue and Market Share
10. Global Tumor Ablation Market Competition, by Manufacturer
10.1. Global Tumor Ablation Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Tumor Ablation Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Tumor Ablation Price by Manufacturer (2017-2017)
10.4. Top 5 Tumor Ablation Manufacturer Market Share
10.5. Market Competition Trend
11. Tumor Ablation Market Forecast (2027-2023)
11.1. Global Tumor Ablation Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Tumor Ablation Market Forecast by Regions (2027-2023)
11.2.1. North America Tumor Ablation Market Forecast (2027-2023)
11.2.1.1. United States Tumor Ablation Market Forecast (2027-2023)
11.2.1.2. Canada Tumor Ablation Market Forecast (2027-2023)
11.2.1.3. Mexico Tumor Ablation Market Forecast (2027-2023)
11.2.2. Europe Tumor Ablation Market Forecast (2027-2023)
11.2.2.1. Germany Tumor Ablation Market Forecast (2027-2023)
11.2.2.2. United Kingdom Tumor Ablations Market Forecast (2027-2023)
11.2.2.3. France Tumor Ablation Market Forecast (2027-2023)
11.2.2.4. Russia Tumor Ablation Market Forecast (2027-2023)
11.2.2.5. Italy Tumor Ablation Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Tumor Ablation Market Forecast (2027-2023)
11.2.3. Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.3.1. China Tumor Ablation Market Forecast (2027-2023)
11.2.3.2. Japan Tumor Ablation Market Forecast (2027-2023)
11.2.3.3. Korea Tumor Ablation Market Forecast (2027-2023)
11.2.3.4. India Tumor Ablation Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Tumor Ablation Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.4. South America Tumor Ablation Market Forecast (2027-2023)
11.2.4.1. Brazil Tumor Ablation Market Forecast (2027-2023)
11.2.4.2. Argentina Tumor Ablation Market Forecast (2027-2023)
11.2.4.3. Columbia Tumor Ablation Market Forecast (2027-2023)
11.2.4.4. Rest of South America Tumor Ablation Market Forecast (2027-2023)
11.2.5. Middle East and Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Tumor Ablation Market Forecast (2027-2023)
11.2.5.2. UAE Tumor Ablation Market Forecast (2027-2023)
11.2.5.3. Egypt Tumor Ablation Market Forecast (2027-2023)
11.2.5.4. Nigeria Tumor Ablation Market Forecast (2027-2023)
11.2.5.5. South Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Tumor Ablation Market Forecast (2027-2023)
11.3. Tumor Ablation Market Forecast by Technology (2027-2023)
11.3.1. Global Tumor Ablation Sales Forecast by Technology (2027-2023)
11.3.2. Global Tumor Ablation Sales Market Share Forecast by Technology (2027-2023)
11.4. Tumor Ablation Market Forecast by Treatment (2027-2023)
11.4.1. Global Tumor Ablation Sales Forecast by Treatment (2027-2023)
11.4.2. Global Tumor Ablation Sales Market Share Forecast by Treatment (2027-2023)
11.5. Tumor Ablation Market Forecast by Application (2027-2023)
11.5.1. Global Tumor Ablation Sales Forecast by Application (2027-2023)
11.5.2. Global Tumor Ablation Sales Market Share Forecast by Application (2027-2023)
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Tumor Ablation Market, By Technology
5.1. Introduction
5.2. Global Tumor Ablation Sales, Revenue and Market Share by Technology (2017-2027)
5.2.1. Global Tumor Ablation Sales and Sales Share by Technology (2017-2027)
5.2.2. Global Tumor Ablation Revenue and Revenue Share by Technology (2017-2027)
5.3. Radiofrequency
5.3.1. Global Radiofrequency Sales and Growth Rate (2017-2027)
5.4. Microwave ablation
5.4.1. Global Microwave ablation Sales and Growth Rate (2017-2027)
5.5. Cryoablation
5.5.1. Global Cryoablation Sales and Growth Rate (2017-2027)
5.6. Other ablation technologies
5.6.1. Global Other ablation technologies Sales and Growth Rate (2017-2027)
6. Tumor Ablation Market, By Treatment
6.1. Introduction
6.2. Global Tumor Ablation Sales, Revenue and Market Share by Treatment (2017-2027)
6.2.1. Global Tumor Ablation Sales and Sales Share by Treatment (2017-2027)
6.2.2. Global Tumor Ablation Revenue and Revenue Share by Treatment (2017-2027)
6.3. Surgical tumor ablation
6.3.1. Global Surgical tumor ablation Sales and Growth Rate (2017-2027)
6.4. Laparoscopic tumor ablation
6.4.1. Global Laparoscopic tumor ablation Sales and Growth Rate (2017-2027)
6.5. Percutaneous tumor ablation
6.5.1. Global Percutaneous tumor ablation Sales and Growth Rate (2017-2027)
7. Tumor Ablation Market, By Application
7.1. Introduction
7.2. Global Tumor Ablation Sales, Revenue and Market Share by Application (2017-2027)
7.2.1. Global Tumor Ablation Sales and Sales Share by Application (2017-2027)
7.2.2. Global Tumor Ablation Revenue and Revenue Share by Application (2017-2027)
7.3. Liver cancer
7.3.1. Global Liver cancer Sales and Growth Rate (2017-2027)
7.4. Breast cancer
7.4.1. Global Breast cancer Sales and Growth Rate (2017-2027)
7.5. Lung cancer
7.5.1. Global Lung cancer Sales and Growth Rate (2017-2027)
7.6. Prostate cancer
7.6.1. Global Prostrate cancer Sales and Growth Rate (2017-2027)
7.7. Other Cancers
7.7.1. Global Other cancers Sales and Growth Rate (2017-2027)
8. Tumor Ablation Market, By Region
8.1. Introduction
8.2. Global Tumor Ablation Sales, Revenue and Market Share by Regions
8.2.1. Global Tumor Ablation Sales by Regions (2017-2027)
8.2.2. Global Tumor Ablation Revenue by Regions (2017-2027)
8.3. North America Tumor Ablation by Countries
8.3.1. North America Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.2. North America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.3.3. North America Tumor Ablation Sales by Countries (2017-2027)
8.3.4. North America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.5.2. United States Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Tumor Ablation Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Tumor Ablation Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Tumor Ablation by Countries
8.4.1. Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.2. Europe Tumor Ablation Revenue and Growth Rate (2017-2027)
8.4.3. Europe Tumor Ablation Sales by Countries (2017-2027)
8.4.4. Europe Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.6.2. UK Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.7.2. France Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Tumor Ablation Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Tumor Ablation Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Tumor Ablation Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.5.2. China Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6.3.
8.5.7. Korea
8.5.7.1. Korea Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.8.2. India Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Tumor Ablation Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.2. South America Tumor Ablation Revenue and Growth Rate (2017-2027)
8.6.3. South America Tumor Ablation Sales by Countries (2017-2027)
8.6.4. South America Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Tumor Ablation Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Tumor Ablation Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Tumor Ablation Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Tumor Ablation Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Tumor Ablation Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Tumor Ablation Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Medtronic Plc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Angiodynamics
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Mermaid Medical
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. HealthTronics
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Galil Medical Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. EDAP TMS S.A.
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Boston Scientific Corporation
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. Sonacare Medical
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Misonix, Inc.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
9.10. Neuwave Medical, Inc.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Sales, Revenue and Market Share
10. Global Tumor Ablation Market Competition, by Manufacturer
10.1. Global Tumor Ablation Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Tumor Ablation Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Tumor Ablation Price by Manufacturer (2017-2017)
10.4. Top 5 Tumor Ablation Manufacturer Market Share
10.5. Market Competition Trend
11. Tumor Ablation Market Forecast (2027-2023)
11.1. Global Tumor Ablation Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Tumor Ablation Market Forecast by Regions (2027-2023)
11.2.1. North America Tumor Ablation Market Forecast (2027-2023)
11.2.1.1. United States Tumor Ablation Market Forecast (2027-2023)
11.2.1.2. Canada Tumor Ablation Market Forecast (2027-2023)
11.2.1.3. Mexico Tumor Ablation Market Forecast (2027-2023)
11.2.2. Europe Tumor Ablation Market Forecast (2027-2023)
11.2.2.1. Germany Tumor Ablation Market Forecast (2027-2023)
11.2.2.2. United Kingdom Tumor Ablations Market Forecast (2027-2023)
11.2.2.3. France Tumor Ablation Market Forecast (2027-2023)
11.2.2.4. Russia Tumor Ablation Market Forecast (2027-2023)
11.2.2.5. Italy Tumor Ablation Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Tumor Ablation Market Forecast (2027-2023)
11.2.3. Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.3.1. China Tumor Ablation Market Forecast (2027-2023)
11.2.3.2. Japan Tumor Ablation Market Forecast (2027-2023)
11.2.3.3. Korea Tumor Ablation Market Forecast (2027-2023)
11.2.3.4. India Tumor Ablation Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Tumor Ablation Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Tumor Ablation Market Forecast (2027-2023)
11.2.4. South America Tumor Ablation Market Forecast (2027-2023)
11.2.4.1. Brazil Tumor Ablation Market Forecast (2027-2023)
11.2.4.2. Argentina Tumor Ablation Market Forecast (2027-2023)
11.2.4.3. Columbia Tumor Ablation Market Forecast (2027-2023)
11.2.4.4. Rest of South America Tumor Ablation Market Forecast (2027-2023)
11.2.5. Middle East and Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Tumor Ablation Market Forecast (2027-2023)
11.2.5.2. UAE Tumor Ablation Market Forecast (2027-2023)
11.2.5.3. Egypt Tumor Ablation Market Forecast (2027-2023)
11.2.5.4. Nigeria Tumor Ablation Market Forecast (2027-2023)
11.2.5.5. South Africa Tumor Ablation Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Tumor Ablation Market Forecast (2027-2023)
11.3. Tumor Ablation Market Forecast by Technology (2027-2023)
11.3.1. Global Tumor Ablation Sales Forecast by Technology (2027-2023)
11.3.2. Global Tumor Ablation Sales Market Share Forecast by Technology (2027-2023)
11.4. Tumor Ablation Market Forecast by Treatment (2027-2023)
11.4.1. Global Tumor Ablation Sales Forecast by Treatment (2027-2023)
11.4.2. Global Tumor Ablation Sales Market Share Forecast by Treatment (2027-2023)
11.5. Tumor Ablation Market Forecast by Application (2027-2023)
11.5.1. Global Tumor Ablation Sales Forecast by Application (2027-2023)
11.5.2. Global Tumor Ablation Sales Market Share Forecast by Application (2027-2023)
no record found